Core Viewpoint - Investors in the Chemical - Specialty sector should consider Novozymes A/S (NVZMY) and Hawkins (HWKN) for potential value opportunities, with NVZMY currently appearing to offer better value based on various financial metrics [1]. Valuation Metrics - Novozymes A/S has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook compared to Hawkins, which has a Zacks Rank of 3 (Hold) [3]. - NVZMY has a forward P/E ratio of 24.53, while HWKN has a higher forward P/E of 31.23, suggesting that NVZMY may be undervalued relative to HWKN [5]. - The PEG ratio for NVZMY is 1.11, compared to HWKN's PEG ratio of 1.95, indicating that NVZMY has a more favorable earnings growth outlook relative to its valuation [5]. - NVZMY's P/B ratio is 2.26, significantly lower than HWKN's P/B ratio of 5.04, further supporting the argument that NVZMY is a better value option [6]. - Based on these metrics, NVZMY has earned a Value grade of B, while HWKN has a Value grade of C, reinforcing the perception of NVZMY as the superior value stock [6]. Earnings Outlook - Novozymes A/S is noted for its improving earnings outlook, which enhances its attractiveness in the current market [7].

Core Viewpoint - Ultrapar Participacoes S.A. (UGP) is currently viewed as a better value opportunity compared to Kinder Morgan (KMI) based on various financial metrics and analyst outlooks [1]. Valuation Metrics - UGP has a forward P/E ratio of 12.74, significantly lower than KMI's forward P/E of 21.84, indicating that UGP may be undervalued relative to KMI [5]. - The PEG ratio for UGP is 1.89, while KMI's PEG ratio stands at 2.44, suggesting that UGP offers better value when considering expected earnings growth [5]. - UGP's P/B ratio is 1.58 compared to KMI's P/B of 2.03, further supporting the notion that UGP is more attractively valued [6]. Analyst Outlook - UGP holds a Zacks Rank of 2 (Buy), indicating a positive earnings estimate revision trend, while KMI has a Zacks Rank of 3 (Hold), reflecting a less favorable outlook [3]. - The stronger estimate revision activity for UGP suggests a more optimistic analyst sentiment compared to KMI, making UGP the preferred choice for value investors [7].

Core Insights - Investing in stocks based on valuation metrics, particularly the price-to-sales (P/S) ratio, can identify opportunities with strong upside potential, especially for unprofitable or early-stage growth companies [1][2] Valuation Metrics - The P/S ratio provides a clearer picture of value when earnings are minimal or volatile, making it particularly valuable for assessing companies in recovery or growth phases [2][5] - A P/S ratio below 1 indicates a good bargain, as investors pay less than a dollar for each dollar of revenue generated [6] - The P/S ratio is preferred over the price-to-earnings (P/E) ratio due to the difficulty of manipulating sales figures compared to earnings [7] Investment Opportunities - Low P/S stocks can offer compelling opportunities, often trading below intrinsic value, making them attractive for investors seeking upside potential [3] - Companies with low P/S ratios and strong fundamentals, such as Hamilton Insurance Group, Macy's Inc., G-III Apparel Group, California Water Service Group, and UFP Industries, are highlighted as having potential for higher returns [4][12] Company Profiles - **Hamilton Insurance Group, Ltd. (HG)**: A specialty insurance and reinsurance company benefiting from strong execution and disciplined capital management, with gross premiums written rising significantly [12][13] - **Macy's Inc. (M)**: Undergoing a transformation with its "Bold New Chapter" program, focusing on digital initiatives and omnichannel retailing, currently holds a Zacks Rank 1 and Value Score of A [14][15] - **G-III Apparel Group (GIII)**: Focuses on product differentiation and international expansion, with owned brands generating higher margins, currently holds a Value Score of A and Zacks Rank 2 [16][17] - **California Water Service Group (CWT)**: One of the largest investor-owned water utilities in the U.S., focusing on expansion through acquisitions and high-quality service delivery, currently holds a Value Score of B and Zacks Rank 2 [18][20] - **UFP Industries (UFPI)**: A holding company benefiting from long-term business plans and product innovation, with a focus on acquisitions to solidify its product portfolio, currently holds a Value Score of A and Zacks Rank 2 [21][22]

I analyze securities based on value investing, an owner's mindset, and a long-term horizon. I don't write sell articles, as those are considered short theses, and I never recommend shorting.I was initially interested in a career in politics, but after reaching a dead-end in 2019 and seeing the financial drain this posed, I choose a path that would make my money work for me and protect me from more setbacks. This brought me to study value investing, in order to grow wealth with risk management in mind.From 2 ...

I aim to invest in companies with perfect qualitative attributes, buy them at an attractive price based on fundamentals, and hold them forever. I hope to publish articles covering such companies approximately 3 times per week, with extensive quarterly follow-ups and constant updates.I manage a concentrated portfolio targeted at avoiding losers and maximizing exposure to big winners. This means that often I'll rate great companies at a 'Hold' because their growth opportunity is below my threshold, or their d ...

Core Viewpoint - Univest Corporation of Pennsylvania (UVSP) is identified as a strong value stock, currently rated with a Zacks Rank 2 (Buy) and an A for Value, indicating it is likely undervalued in the market [3][7]. Valuation Metrics - UVSP has a Price-to-Book (P/B) ratio of 0.98, which is lower than the industry average of 1.17, suggesting it is undervalued compared to its peers [4]. - The Price-to-Sales (P/S) ratio for UVSP stands at 1.89, compared to the industry average of 2.02, further indicating potential undervaluation [5]. - UVSP's Price-to-Cash Flow (P/CF) ratio is 10.53, which is attractive relative to the industry average of 12.74, reinforcing the notion of undervaluation based on cash flow [6]. Investment Outlook - The combination of UVSP's favorable valuation metrics and strong earnings outlook positions it as a compelling investment opportunity for value investors [7].

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors rely on traditional forms of analysis on ke ...

Core Viewpoint - Value investing remains a preferred strategy for identifying strong stocks, focusing on companies believed to be undervalued based on fundamental analysis [2] Company Analysis: Nomura (NMR) - Nomura currently holds a Zacks Rank of 2 (Buy) and a Value grade of A, indicating strong potential as a value stock [4] - The stock's P/E ratio is 9.7, significantly lower than the industry average of 14.57, suggesting it may be undervalued [4] - Nomura's Forward P/E has fluctuated between 6.19 and 11.13 over the past year, with a median of 8.63 [4] - The P/B ratio for Nomura is 0.89, compared to the industry average of 2.46, further indicating attractive valuation [5] - Over the past 12 months, Nomura's P/B has ranged from 0.62 to 0.90, with a median of 0.77 [5] - The P/CF ratio for Nomura stands at 7.63, well below the industry average of 16.98, highlighting its undervaluation based on cash flow strength [6] - Nomura's P/CF has varied between 5.73 and 9.60 in the past year, with a median of 7.23 [6] - Overall, the metrics suggest that Nomura is likely undervalued, making it one of the strongest value stocks in the market [7]

Core Viewpoint - The article emphasizes the importance of value investing and highlights Exelixis (EXEL) as a strong candidate for value investors due to its favorable valuation metrics and earnings outlook [2][4][7]. Company Analysis - Exelixis (EXEL) currently holds a Zacks Rank of 2 (Buy) and an A rating for Value, indicating strong potential for value investors [4]. - The stock has a P/E ratio of 13.5, significantly lower than the industry average of 37.39, suggesting it may be undervalued [4]. - Over the past 12 months, EXEL's Forward P/E has fluctuated between 12.30 and 19.07, with a median of 15.29, indicating variability in market perception [4]. - The PEG ratio for EXEL is 0.65, compared to the industry average of 1.88, further supporting the notion that the stock is undervalued relative to its expected earnings growth [5]. - EXEL's P/S ratio stands at 5.02, which is lower than the industry average of 7.05, reinforcing its attractiveness as a value investment [6]. - Overall, the combination of these metrics positions Exelixis as one of the strongest value stocks in the market, particularly given its positive earnings outlook [7].

Thanks to our global coverage we've ramped up our global macro commentary on our marketplace service here on Seeking Alpha, The Value Lab . We focus on long-only value ideas, where we try to find international mispriced equities and target a portfolio yield of about 4% . We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value-investor, serious about protecting your wealth, us at the Value Lab might be of inspiration.State S ...